Overview

Treatment of Oral Warts in HIV+ Patients

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This is a study to test lozenges of interferon-alpha that are dissolved in the mouth as a treatment of oral warts in HIV-positive adults. The hypothesis of this study is that interferon-alpha will be safe and that a higher percentage of subjects given interferon-alpha will experience a complete or nearly complete remission of their oral warts compared to subjects given placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Amarillo Biosciences, Inc.
Treatments:
Interferon-alpha
Interferons